Abstract:<h3 class="Heading">Background</h3><p class="Para">Exosomes from cancer cells or immune cells, carrying bio-macromolecules or microRNAs (miRNAs), participate in tumor pathogenesis and progression by modulating microenvironment. Our study aims to investigate the role of these microRNA-501-3p (miR-501-3p) containing exosomes derived from tumor-associated macrophage (TAM) in the progression of pancreatic ductal adenocarcinoma (PDAC).</p><h3 class="Heading">Methods</h3><p class="Para">Firstly, the function of TAM recruitment in PDAC tissues was assessed, followed by identification of the effects of M2 macrophage-derived exosomes on PDAC cell activities and tumor formation and metastasis in mice. In silico analysis was conducted to predict differentially expressed genes and regulatory miRNAs related to PDAC treated with macrophages, which determined miR-501-3p and TGFBR3 for subsequent experiments. Next, gain- and loss-of-function experiments were performed to examine their role in PDAC progression with the involvement of the TGF-β signaling pathway.</p><h3 class="Heading">Results</h3><p class="Para">TAM recruitment in PDAC tissues was associated with metastasis. Highly expressed miR-501-3p was observed in PDAC tissues and TAM-derived exosomes. Both M2 macrophage-derived exosomes and miR-501-3p promoted PDAC cell migration and invasion, as well as tumor formation and metastasis in nude mice. MiR-501-3p was verified to target TGFBR3. PDAC cells presented with down-regulated TGFBR3, which was further decreased in response to M2 macrophage treatment. TGF-β signaling pathway activation was implicated in the promotion of miR-501-3p in PDAC development. The suppression of macrophage-derived exosomal miR-501-3p resulted in the inhibition of tumor formation and metastasis in vivo.</p><h3 class="Heading">Conclusion</h3><p class="Para">M2 macrophage-derived exosomal miR-501-3p inhibits tumor suppressor TGFBR3 gene and facilitates the development of PDAC by activating the TGF-β signaling pathway, which provides novel targets for the molecular treatment of PDAC.</p>

Mechanism of Tumor-Associated Macrophages Promoting the Progression of Pancreatic Cancer

Tumor-associated Macrophages Promote Pancreatic Ductal Adenocarcinoma Progression by Inducing Epithelial-to-mesenchymal Transition

Tumor-Associated Macrophages in Tumor Immunity (vol <i>11</i>, <i>583084</i>, <i>2020</i>)

Roles of Tumor-Associated Macrophages in Tumor Progression: Implications on Therapeutic Strategies

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies

Advances in microenvironment and metastasis of pancreatic cancer

Tumor-Associated Macrophages: A Potential Target For Cancer Therapy

Functional Significance of Macrophages in Pancreatic Cancer Biology

Exploring the Tumor Promoting Role of Anti-Tumor Macrophage: a Developmental Perspective

Tumor-associated macrophages: orchestrators of cholangiocarcinoma progression

Tumor-associated Macrophages in Lung Carcinoma: from Mechanism to Therapy.

The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy

Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma

Progress in the Research of Tumor Therapy Aimed at Tumor Associated Macrophages

Fibroblasts and Macrophages Synergistically Contribute to Pro-Tumorigenic Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma

Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies

Tumor-associated macrophages: an accomplice in solid tumor progression

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor

CTHRC1+ fibroblasts and SPP1+ macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma

Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway